chel24 Apr 2020 17:01
well, a fast fall in current circumstances is always possible, but remember before you sell, that Angle has been preparing for the current FDA process for 10 years - this is the company's moment in the sun! Previous falls have been for testing delays, funding rounds, etc, but now Parsortix is fully tested, peer reviewed by many first class institutions (as far-outperforming every other liquid biopsy technology), and Angle is fully funded into 2021. Other companies that have achieved de Novo FDA approval have seen their share prices rise by many multiples....